HEC Pharm Group is an emerging pharmaceutical company specialized in development, production and marketing of quality and affordable generics, APIs and intermediates for worldwide markets. HEC also provides services for contract R&D and manufacturing.
All manufacture facilities of HEC have been GMP certified by both U.S FDA and European authorities. HEC can provide the value added formulations based on its strong R&D capability. HEC has Zidovudine tablets approved by U.S FDA and Azithromycin tablets approved by German BfArM and WHO.
The company also offers qualified APIs with DMF and CEP, such as Telaprevir, Atorvastatin, Ticagrelor, Clopidogrel, Azilsartan, etc.
